Pityaratstian, Nuttorn2009-05-272009-05-272005-09-21Pityaratstian N. Advances in alternative pharmacotherapy of ADHD. Journal of the Medical Association of Thailand. 2005 Sep; 88 Suppl 4(): S357-62http://imsear.searo.who.int/handle/123456789/39859Chotmaihet Thangphaet. 32 references.Several alternatives to psychostimulants have been developed and expanded the variability of the treatment of ADHD. Clonidine is a good option for managing core behavioral symptoms, especially hyperactivity and impulsivity. Bupropion and venlafaxine seem potentially promising. Significant new options include norepinephrine reuptake inhibitors, such as atomoxetine, and possibly selective dopamine agonists. Central anticholinesterases, such as donepezil, may improve core ADHD symptoms.engAdrenergic alpha-Agonists --therapeutic useAntidepressive Agents, Tricyclic --therapeutic useAttention Deficit Disorder with Hyperactivity --drug therapyBupropion --therapeutic useClonidine --therapeutic useHumansIndans --therapeutic usePiperidines --therapeutic useTreatment OutcomeJournal Article